2022
DOI: 10.1007/s12035-022-02859-7
|View full text |Cite
|
Sign up to set email alerts
|

Resveratrol and neuroprotection: an insight into prospective therapeutic approaches against Alzheimer’s disease from bench to bedside

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
23
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
10

Relationship

4
6

Authors

Journals

citations
Cited by 48 publications
(31 citation statements)
references
References 252 publications
1
23
0
Order By: Relevance
“…Moreover, the levels of the cytokines had a positive correlation with hyperactive behavior. Previous studies have demonstrated that herbal medicines and natural compounds exert beneficial effects on behavioral changes and neurological disorders through antineuroinflammatory activities and neuroprotective effects [75][76][77][78]. In this study, the oral administration of SPS reduced the levels of TNF-α and IL-6 significantly in the PFC, as well as in LPSstimulated BV2 microglial cells.…”
Section: Discussionsupporting
confidence: 50%
“…Moreover, the levels of the cytokines had a positive correlation with hyperactive behavior. Previous studies have demonstrated that herbal medicines and natural compounds exert beneficial effects on behavioral changes and neurological disorders through antineuroinflammatory activities and neuroprotective effects [75][76][77][78]. In this study, the oral administration of SPS reduced the levels of TNF-α and IL-6 significantly in the PFC, as well as in LPSstimulated BV2 microglial cells.…”
Section: Discussionsupporting
confidence: 50%
“…Neurodegenerative disorders (NDDs) progressively affect millions worldwide as significant causes of disability and death, despite progress in considering various dysregulated routes in the pathophysiology of NDDs. The main pathophysiological processes of NDDs are still unknown [1][2][3][4]. Spinal cord injury (SCI) is an NDD that causes sensory-motor impairment and significantly lowers the standard of living.…”
Section: Introductionmentioning
confidence: 99%
“…In the retina of diabetic rats, oral treatment with RES-assembled gold nanoparticles (AuNPs) inhibited the activation of vascular endothelial growth factor (VEGF) 1, monocyte chemotactic protein 1 (MCP-1), intercellular adhesion molecule 1 (ICAM-1), extracellular signal-regulated kinase (ERK) 1/2, NF- κ B, TNF- α , IL-6, and IL-1 β genes. Therefore, RES-assembled AuNPs could be used to treat diabetic retinopathy [ 145 ]. There has yet to be a report on a diabetic human clinical trial with RES nanoformulation.…”
Section: Nanoformulations In Diabetes Treatmentmentioning
confidence: 99%